Biocon Waits On FDA Insulin Inspection

Indian Company Seeks US Agency Stance On Mutual Recognition Agreement Route

 
• By Anju Ghangurde
  
Firms Await Regulatory Inspections
Indian Firms Face Limited Visibility In Inspection Schedules • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products